Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the study page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedA minor site revision was issued (Revision: v3.4.2), replacing the previous v3.4.1 and removing the government funding lapse notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide government funding notice and upgraded from v3.4.0 to v3.4.1; this does not affect the study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary display and status indicators (Results Submitted, Last Update Submitted that Met QC Criteria, Last Update Posted) and updated the revision to v3.4.0, while removing older indicators (No Results Posted, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4).SummaryDifference0.3%

- Check62 days agoChange DetectedThe page shows a revision label updated from v3.3.3 to v3.3.4. No substantive changes to the study details or page content are evident; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a Texas site to the Locations; updated the page revision to v3.3.3 and removed the previous Texas Locations reference and HHS Vulnerability Disclosure.SummaryDifference0.2%

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.